EC Healthcare Acquires 14.6% Stake in Target Company

Reuters01-02

EC Healthcare Acquires 14.6% Stake in Target Company

EC Healthcare has announced a connected transaction involving the acquisition of a 14.6313% stake in a target company. The transaction was formalized through a sale and purchase agreement dated 31 December 2025, between an indirect wholly-owned subsidiary of EC Healthcare and the seller. Following the acquisition, EC Healthcare will increase its ownership in the target company, which was previously held as to 70% by EC Healthcare and 30% by the seller. The acquisition was approved by the Board, including independent non-executive directors, and was determined to be on normal commercial terms, fair and reasonable, and in the interest of the company and its shareholders. The transaction is subject to reporting and announcement requirements under Chapter 14A of the Hong Kong Listing Rules but is exempt from circular, independent financial advice, and shareholder approval requirements, as all applicable percentage ratios are less than 5%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. EC Healthcare published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260102-11974341), on January 01, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2600603409?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-02 07:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2600603409","market":"nz","top_or_hot":-1,"title":"EC Healthcare Acquires 14.6% Stake in Target Company","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      EC Healthcare Acquires 14.6% Stake in Target Company\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        EC Healthcare has announced a connected transaction involving the acquisition of a 14.6313% stake in a target company. The transaction was formalized through a sale and purchase agreement dated 31 December 2025, between an indirect wholly-owned subsidiary of EC Healthcare and the seller. Following the acquisition, EC Healthcare will increase its ownership in the target company, which was previously held as to 70% by EC Healthcare and 30% by the seller. The acquisition was approved by the Board, including independent non-executive directors, and was determined to be on normal commercial terms, fair and reasonable, and in the interest of the company and its shareholders. The transaction is subject to reporting and announcement requirements under Chapter 14A of the Hong Kong Listing Rules but is exempt from circular, independent financial advice, and shareholder approval requirements, as all applicable percentage ratios are less than 5%.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. EC Healthcare published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260102-11974341), on January 01, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EC Healthcare Acquires 14.6% Stake in Target Company</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEC Healthcare Acquires 14.6% Stake in Target Company\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-01-02 07:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      EC Healthcare Acquires 14.6% Stake in Target Company\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        EC Healthcare has announced a connected transaction involving the acquisition of a 14.6313% stake in a target company. The transaction was formalized through a sale and purchase agreement dated 31 December 2025, between an indirect wholly-owned subsidiary of EC Healthcare and the seller. Following the acquisition, EC Healthcare will increase its ownership in the target company, which was previously held as to 70% by EC Healthcare and 30% by the seller. The acquisition was approved by the Board, including independent non-executive directors, and was determined to be on normal commercial terms, fair and reasonable, and in the interest of the company and its shareholders. The transaction is subject to reporting and announcement requirements under Chapter 14A of the Hong Kong Listing Rules but is exempt from circular, independent financial advice, and shareholder approval requirements, as all applicable percentage ratios are less than 5%.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. EC Healthcare published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260102-11974341), on January 01, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1593","symbol_name":"医美概念股","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260101:nNDL3RJxPv:1","article_id":"2600603409","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2600603409","pubTimestamp":1767311971,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"EC Healthcare has announced a connected transaction involving the acquisition of a 14.6313% stake in a target company. The transaction was formalized through a sale and purchase agreement dated 31 December 2025, between an indirect wholly-owned subsidiary of EC Healthcare and the seller. Following the acquisition, EC Healthcare will increase its ownership in the target company, which was previously held as to 70% by EC Healthcare and 30% by the seller. The acquisition was approved by the Board, including independent non-executive directors, and was determined to be on normal commercial terms, fair and reasonable, and in the interest of the company and its shareholders. The transaction is subject to reporting and announcement requirements under Chapter 14A of the Hong Kong Listing Rules but is exempt from circular, independent financial advice, and shareholder approval requirements, as all applicable percentage ratios are less than 5%.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1593":"医美概念股","BK1215":"特殊消费者服务","BK1511":"疑似财技股","02138":"医思健康"},"translate_title":"EC Healthcare收购目标公司14.6%股权","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02138":0.9},"content_text":"EC Healthcare Acquires 14.6% Stake in Target Company\n    \n\n        EC Healthcare has announced a connected transaction involving the acquisition of a 14.6313% stake in a target company. The transaction was formalized through a sale and purchase agreement dated 31 December 2025, between an indirect wholly-owned subsidiary of EC Healthcare and the seller. Following the acquisition, EC Healthcare will increase its ownership in the target company, which was previously held as to 70% by EC Healthcare and 30% by the seller. The acquisition was approved by the Board, including independent non-executive directors, and was determined to be on normal commercial terms, fair and reasonable, and in the interest of the company and its shareholders. The transaction is subject to reporting and announcement requirements under Chapter 14A of the Hong Kong Listing Rules but is exempt from circular, independent financial advice, and shareholder approval requirements, as all applicable percentage ratios are less than 5%.\n      \n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. EC Healthcare published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260102-11974341), on January 01, 2026, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.1","shortVersion":"4.36.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2600603409","isCrawlerRequest":true}